Brown Justin D, Luttrell M Page, Berghaus Roy D, Kistler Whitney, Keeler Shamus P, Howey Andrea, Wilcox Benjamin, Hall Jeffrey, Niles Larry, Dey Amanda, Knutsen Gregory, Fritz Kristin, Stallknecht David E
Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. jubrown1mailto:@uga.edu
J Wildl Dis. 2010 Jul;46(3):896-911. doi: 10.7589/0090-3558-46.3.896.
Serologic testing to detect antibodies to avian influenza (AI) virus has been an underused tool for the study of these viruses in wild bird populations, which traditionally has relied on virus isolation and reverse transcriptase-polymerase chain reaction (RT-PCR). In a preliminary study, a recently developed commercial blocking enzyme-linked immunosorbent assay (bELISA) had sensitivity and specificity estimates of 82% and 100%, respectively, for detection of antibodies to AI virus in multiple wild bird species after experimental infection. To further evaluate the efficacy of this commercial bELISA and the agar gel immunodiffusion (AGID) test for AI virus antibody detection in wild birds, we tested 2,249 serum samples collected from 62 wild bird species, representing 10 taxonomic orders. Overall, the bELISA detected 25.4% positive samples, whereas the AGID test detected 14.8%. At the species level, the bELISA detected as many or more positive serum samples than the AGID in all 62 avian species. The majority of positive samples, detected by both assays, were from species that use aquatic habitats, with the highest prevalence from species in the orders Anseriformes and Charadriiformes. Conversely, antibodies to AI virus were rarely detected in the terrestrial species. The serologic data yielded by both assays are consistent with the known epidemiology of AI virus in wild birds and published reports of host range based on virus isolation and RT-PCR. The results of this research are also consistent with the aforementioned study, which evaluated the performance of the bELISA and AGID test on experimental samples. Collectively, the data from these two studies indicate that the bELISA is a more sensitive serologic assay than the AGID test for detecting prior exposure to AI virus in wild birds. Based on these results, the bELISA is a reliable species-independent assay with potentially valuable applications for wild bird AI surveillance.
血清学检测以检测禽流感(AI)病毒抗体,一直是在野生鸟类种群中研究这些病毒时未得到充分利用的工具,传统上对野生鸟类的研究依赖于病毒分离和逆转录聚合酶链反应(RT-PCR)。在一项初步研究中,一种最近开发的商业阻断酶联免疫吸附测定(bELISA),在实验感染后检测多种野生鸟类物种中AI病毒抗体的灵敏度和特异性估计分别为82%和100%。为了进一步评估这种商业bELISA和琼脂凝胶免疫扩散(AGID)试验在野生鸟类中检测AI病毒抗体的效果,我们检测了从62种野生鸟类收集的2249份血清样本,这些鸟类代表10个分类目。总体而言,bELISA检测出25.4%的阳性样本,而AGID试验检测出14.8%。在物种水平上,bELISA在所有62种鸟类中检测到的阳性血清样本数量与AGID一样多或更多。两种检测方法检测到的大多数阳性样本,来自使用水生栖息地的物种,其中雁形目和鸻形目的物种患病率最高。相反,在陆生物种中很少检测到AI病毒抗体。两种检测方法产生的血清学数据,与野生鸟类中已知的AI病毒流行病学以及基于病毒分离和RT-PCR的宿主范围已发表报告一致。这项研究的结果也与上述评估bELISA和AGID试验对实验样本性能的研究一致。总体而言,这两项研究的数据表明,在检测野生鸟类先前是否接触过AI病毒方面,bELISA是一种比AGID试验更敏感的血清学检测方法。基于这些结果,bELISA是一种可靠的不依赖物种的检测方法,在野生鸟类AI监测中具有潜在的重要应用价值。